Development of in vitro biopharmaceutics tools for predicting the bioavailability of subcutaneously injected monoclonal antibodies and oligonucleotides

被引：0
|
作者：
Somby, Karin [1 ,2 ]
Campagna, Valerio [2 ]
Sanchez-Felix, Manuel V. [3 ,4 ]
Forbes, Ben [1 ]
Vllasaliu, Driton [1 ]
机构：
[1] Kings Coll London, Inst Pharmaceut Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England
[2] Novartis Pharm AG, Basel, Switzerland
[3] Novartis Pharm AG, Cambridge, MA USA
[4] Halozyme Therapeut, San Diego, CA USA
来源：
EXPERT OPINION ON DRUG DELIVERY | 2024年 / 21卷 / 09期
关键词：
SiRNA; GalNAc; mAbs; Biologics; Absorption; Pharmacokinetics; Physiologically based biopharmaceutics modeling (PBBM); SCISSOR; MODEL;
D O I：
10.1080/17425247.2024.2403469
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1307 / 1310
页数：4
相关论文
共 31 条
  • [1] In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies
    Bown, Hanne Kinnunen
    Bonn, Catherine
    Yohe, Stefan
    Yadav, Daniela Bumbaca
    Patapoff, Thomas W.
    Daugherty, Ann
    Mrsny, Randall J.
    JOURNAL OF CONTROLLED RELEASE, 2018, 273 : 13 - 20
  • [2] Predicting Human Bioavailability of Subcutaneously Administered Fusion Proteins and Monoclonal Antibodies Using Human Intravenous Clearance or Antibody Isoelectric Point
    Zou, Peng
    AAPS JOURNAL, 2023, 25 (03):
  • [3] Predicting Human Bioavailability of Subcutaneously Administered Fusion Proteins and Monoclonal Antibodies Using Human Intravenous Clearance or Antibody Isoelectric Point
    Peng Zou
    The AAPS Journal, 25
  • [4] Predicting Human Bioavailability of Subcutaneously Administered Monoclonal Antibodies Using Non-human Primate Linear Clearance and Antibody Isoelectric Point
    Peng Zou
    The AAPS Journal, 25
  • [5] Predicting Human Bioavailability of Subcutaneously Administered Monoclonal Antibodies Using Non-human Primate Linear Clearance and Antibody Isoelectric Point
    Zou, Peng
    AAPS JOURNAL, 2023, 25 (04):
  • [6] Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro/in-silico approach
    Hanafy, Belal I.
    Trayton, Isabelle
    Sundqvist, Monika
    Caldwell, Jenna
    Mody, Neil
    Day, Katie
    Mazza, Mariarosa
    JOURNAL OF CONTROLLED RELEASE, 2025, 380 : 715 - 724
  • [7] Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies
    Lou, Hao
    Hageman, Michael J.
    PHARMACEUTICAL RESEARCH, 2021, 38 (03) : 451 - 460
  • [8] Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies
    Hao Lou
    Michael J. Hageman
    Pharmaceutical Research, 2021, 38 : 451 - 460
  • [9] Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
    Sanchez-Felix, Manuel
    Burke, Matt
    Chen, Hunter H.
    Patterson, Claire
    Mittal, Sachin
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 167 : 66 - 77
  • [10] Predicting Human Subcutaneous Bioavailability of Therapeutic Monoclonal Antibodies from Systemic Clearance and Volume of Distribution
    Milewski, Mikolaj
    Murashov, Mikhail
    Kapoor, Yash
    Zhang, Jingtao
    Zhu, Wei
    Cueto, Maria A.
    Buist, Nicole
    MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 4947 - 4959
1234